Open access is a fantastic opportunity to make science accessible to all. Find out how to get all of the benefits without fearing the predators in our new podcast!
Our new educational resource, an infographic on ORCID, is now available on the Open Pharma website.
Use of preprints is increasing rapidly, with the number of preprints posted to repositories each month almost doubling in the past year
With CRediT, ORCID and Publons integrated into Editorial Manager®, we aim for these transparency tools to be easy, standard steps in the publishing process
Open access publishing is on the rise, providing both opportunities and challenges for publishers, academics, funding bodies and pharma. However, academic authors collaborating with pharma prefer to publish in journals with the highest impact factor possible, and open access is not necessarily the authors’ priority. In our Open Pharma workstreams, we have identified a strong … Continue reading Open access education: time for a new approach?
A summary of the first Open Pharma round table meeting